Research on A Medicine Doesn't End on the Initial Approval by the FDA. Eli Lilly and Company's Chief Medical Officer Shares Why Ongoing Research Helps Us Better Understand A Medicine’s Full Value.

Research is a critical part of the development of new medicines, but it doesn’t stop once the medicine is approved by the U.S. Food and Drug Administration (FDA). In fact, that’s when post-approval research and monitoring begin and they help all health care stakeholders, including physicians and patients, to better understand the full value of the medicine.

Ready to Get Involved?

Or sign up to stay informed: